Updated Warnings on Popular Weight-Loss Drugs Raise Fresh Safety Questions
So, there’s been an important update from Australia’s main medicines watchdog, the Therapeutic Goods Administration, and it’s creating a big conversation around some of the most widely used weight-loss and diabetes medications. These are the GLP-1 drugs you’ve probably heard about — names like Ozempic, Wegovy, Saxenda, Trulicity and Mounjaro. They’ve become incredibly popular, not just for managing type 2 diabetes, but also for helping people lose weight. Now, these medications haven’t been linked provenly to any mental health effects, but new warnings have been added out of precaution, and that’s what everyone is talking about.
Also Read:According to the TGA, updated product information is being rolled out so that patients and doctors are aware of a potential — but unconfirmed — risk of suicidal thoughts or unusual changes in mood. This doesn’t mean the drugs cause these issues. In fact, investigations in Australia, the US and other countries have stressed that evidence is not strong enough to establish a direct causal link. Still, reports have been received, and because these medicines are now used by so many people, it’s being treated carefully.
What the TGA is basically saying is that anyone taking these medications should pay attention to their mental health and let their doctor know if anything feels off — things like unexpected mood swings, depression, or thoughts that are out of character. There’s an understanding that mental health, weight loss, and chronic conditions are deeply connected. Rapid weight changes, for example, can sometimes be emotionally challenging, and some people already have existing vulnerabilities. So the updated warning is more about awareness than alarm.
Another significant update involves Mounjaro, also known as tirzepatide. The regulator has added a new precaution noting that this drug may reduce the effectiveness of oral contraceptives, especially when someone first starts the medication or increases their dose. This doesn’t mean contraception definitely fails — it just means the risk cannot be ruled out. Because the drug slows digestion, it might also slow the absorption of birth control pills. As a result, patients are now being advised to use a non-oral contraceptive or add a barrier method for about four weeks when starting or increasing the dose.
All GLP-1 drugs also come with a firm reminder that they should not be used during pregnancy.
Researchers have been studying this whole picture for the past couple of years, and results vary. Some studies show no link between these drugs and psychiatric symptoms, while others observe a small increase in reports of depression or anxiety. With more than half a million Australians estimated to be using these medications, it’s natural for regulators to refine safety information as more real-world data appears.
For now, the takeaway is simple: the medicines aren’t being declared unsafe, but users are being encouraged to stay aware, stay informed, and stay connected with their healthcare providers while taking them.
Read More:
0 Comments